Therapeutic angiogenesis for critical limb ischemia
- 1 March 2014
- journal article
- review article
- Published by Elsevier BV in Seminars in Vascular Surgery
- Vol. 27 (1), 23-31
- https://doi.org/10.1053/j.semvascsurg.2014.10.001
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery DiseaseBioMed Research International, 2013
- Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemiaJournal of Vascular Surgery, 2012
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemiaJournal of Vascular Surgery, 2006
- Prevalence of and Risk Factors for Peripheral Arterial Disease in the United StatesCirculation, 2004
- Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trialJournal of Vascular Surgery, 2002
- The Results of Spinal Cord Stimulation in Critical Limb Ischaemia:a ReviewEuropean Journal of Vascular and Endovascular Surgery, 2001
- Prostanoids for Chronic Critical Leg IschemiaAnnals of Internal Medicine, 1999
- Outcome of unreconstructed chronic critical leg ischaemiaEuropean Journal of Vascular and Endovascular Surgery, 1996
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992